Integrating the Latest Therapeutic Advances to Optimize the Care of Veterans With Multiple Myeloma

Integrating the Latest Therapeutic Advances to Optimize the Care of Veterans With Multiple Myeloma

Thursday, May 23, 2019 in San Antonio, Texas
Live Meeting -- Audie L. Murphy Memorial VA Hospital, 8:00 AM CT
Pathology Conference Room

Agenda

  • When Should Systemic Myeloma Treatment Be Initiated?
  • Individualized Approaches to Frontline Treatment Selection
  • Transplantation, Consolidation, and Maintenance Strategies and the Role of MRD in Monitoring Treatment Response
  • Therapeutic Strategies After First Relapse Following Initial Therapy
  • Current Treatment Options for Patients With Late Relapse
  • Current Supportive Care Strategies, Including Emerging Treatment Approaches for Myeloma-Related Bone Disease

Faculty

Faculty
Prashant Kapoor, MD

Assistant Professor of Medicine and Oncology
Consultant
Department of Hematology
Mayo Clinic
Rochester, Minnesota

Program Overview
Expert guidance on the latest treatment of multiple myeloma in 1-hour interactive meetings, with an associated downloadable slideset and PDF resource available on the CCO Web site to enhance the information presented at the live meetings.

Goal Statement
The goal of this activity is to improve VHA clinicians’ competence in providing optimal care while considering the unique needs of veterans with multiple myeloma.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare providers who care for veterans with myeloma.

Learning Objectives 

  • Integrate timely systemic treatment for appropriate patients based on newly revised multiple myeloma diagnosis and staging criteria
  • Plan individualized treatment strategies for patients with multiple myeloma through consideration of the available clinical data as well as risk assessment, comorbidities, and patient age/fitness and preferences
  • Describe the efficacy and safety evidence of novel combination therapeutic regimens for patients with multiple myeloma
  • Manage disease-related and treatment-related symptoms in patients with multiple myeloma

Accreditation

Physician Continuing Medical Education

Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statement
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
1.0 contact hour may be earned for successful completion of this activity.

Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 1.0 contact hour. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3 weeks.

Pharmacist Continuing Education

Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
This program has been assigned ACPE Universal Activity 0797-9999-19-035-L01-P. This program is designated for up to 1.0 contact hour (0.10 CEUs) of continuing pharmacy education credit. 

Type of Activity: Application

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.